Show Summary Details
Page of

Diseases of the veins and lymphatics 

Diseases of the veins and lymphatics
Author(s):
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 15 September 2019

Varicose veins and chronic venous disorders are a common pathology affecting approximately a third of the Western population. However, pathophysiology and natural history of venous disease remains incompletely understood and is multifactorial in aetiology. Although many patients with varicose veins remain asymptomatic, complications including bleeding, thrombophlebitis, ulceration, and significant functional impairment due to a wide range of symptoms can occur, and warrant further investigation and treatment. Evidence-based guidelines have been published recently and are described in this chapter. The use of compression in the management of varicose veins has been successfully employed for hundreds of years both as a means of primary treatment and following therapy; however, evidence to support its use as primary management in minimally invasive therapies is lacking. Although compression and vein ablation are considered the main forms of treatment, phlebotrophic medical therapies also exist and may help to improve oedema in association with varicose veins.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.